Ahmed Rabie

Dr. Ahmed Rabie

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2025 in Journal of Robotic Surgery
Verified
Journal Article
Closed access
PDF file
MAMohammed Al-Ogaili
Mohammed Al-Ogaili
AVArjun Venkatesh
Arjun Venkatesh
JDJapnit Dham
Japnit Dham
ARAhmed Rabie
Ahmed Rabie
MBMaida Bada
Maida Bada
MBMaurizio Buscarini
Maurizio Buscarini

18 August 2026 in BJUI Compass
Verified
Journal Article
Open access
MEMohamed Elsaqa
Mohamed Elsaqa
ARAhmed Rabie
Ahmed Rabie
IFIsrael Franco
Israel Franco
AFAndrew Fishman
Andrew Fishman
WDWayne Debeatham
Wayne Debeatham
MGMichael Grasso
Michael Grasso
Objectives: This study aimed to report the impact of minimally invasive partial nephrectomy (PN) on short‐ and long‐term renal functional outcomes through a single‐institution, long‐term experience. Materials and methods: We retrospectively reviewed consecutive patients who underwent retroperitoneal laparoscopic and/or robotic‐assisted PN for renal masses by a single surgeon between 2016 and 2025. A multimodal perioperative renal‐protective protocol was routinely utilized. Baseline estimated glomerular filtration rate (eGFR) was compared with early and late postoperative eGFR changes surveilled over a 2‐year period post‐PN. Multivariate regression analysis of multiple variables was performed for the association with change in eGFR at 2‐year follow‐up. Results: A total of 281 patients with a mean (standard deviation [SD]) age of 67.70 (±10.05) years were included. Mean (SD) baseline serum creatinine and eGFR were 1.04 (±0.31) mg/dL and 74.08 (±19.28) mL/min, respectively. Mean eGFR showed an early postoperative significant decline to 63.98 ± 19.8 mL/min at 2 weeks, followed by delayed recovery at 6 months (69.23 ± 20.87) and then stabilization through 1‐ (69.4 ± 19.26) and 2‐year (68.15 ± 19.67) follow‐up. Multivariate logistic regression analysis identified renal mass size ( p < 0.001, odds ratio [OR] = 4.78, 95% confidence interval [CI]: 3.34 to 6.23) and preop eGFR ( p < 0.001, OR = 0.13, 95% CI: 0.06 to 0.2) as the independent significant predictors of functional decline at 2‐year follow‐up, whereas other variables including warm ischaemia time (WIT) were statistically insignificant. Conclusion: After PN, renal function demonstrates a pattern of early decline followed by substantial recovery over time. Tumour size and preoperative eGFR were the main predictors of late eGFR changes. With proper surgical techniques and perioperative renal‐protective strategies, the effect of WIT can be mitigated.

21 April 2026 in Journal of Robotic Surgery
Verified
Journal Article
Closed access
PDF file
ARAhmed Rabie
Ahmed Rabie
ZDZach Dovey
Zach Dovey
CFCristina Falavolti
Cristina Falavolti
RPRocco Papalia
Rocco Papalia
SSStefano Signore
Stefano Signore
OZOSAMA ZAYTOUN
OSAMA ZAYTOUN

26 May 2026 in Journal of Robotic Surgery
Verified
Journal Article
Closed access
ARAhmed Rabie
Ahmed Rabie
ZDZachary Dovey
Zachary Dovey
CFCristina Falavolti
Cristina Falavolti
RPRocco Papalia
Rocco Papalia
SSStefano Signore
Stefano Signore
OZOsama Zaytoun
Osama Zaytoun


29 May 2026 in Frontiers in Urology
Verified
Journal Article
Open access
PDF file
ARAhmed Rabie
Ahmed Rabie
MBMaurizio Buscarini
Maurizio Buscarini
OZOsama Zaytoun
Osama Zaytoun
Background: Early detection of clinically significant prostate cancer (csPCa) remains a major challenge in urologic oncology. Although prostate-specific antigen (PSA) screening and systematic transrectal ultrasound– guided biopsy has historically been the main diagnostic approaches, these strategies are associated with both overdiagnosis of indolent disease and underdetection of clinically significant tumors. Recent advances in imaging technologies—including multiparametric magnetic resonance imaging (mpMRI), high-resolution micro-ultrasound (MUS), and prostate-specific membrane antigen positron emission tomography (PSMA PET)—have significantly improved the diagnostic pathway for prostate cancer. In parallel, artificial intelligence (AI)–based algorithms have emerged as promising tools for enhancing image interpretation and reducing diagnostic variability. Objective: This review aims to summarize current evidence regarding the diagnostic performance of micro- ultrasound, mpMRI, and PSMA PET in prostate cancer detection and to explore the potential role of artificial intelligence in integrating these imaging modalities to improve diagnostic accuracy. Methods: A systematic literature search was performed using PubMed and MEDLINE databases for articles published between January 2013 and December 2024. The following search strategy was employed using combinations of MeSH terms and keywords: (‘prostate cancer’ OR ‘prostate neoplasm’ OR ‘prostatic carcinoma’) AND (‘micro-ultrasound’ OR ‘high-resolution micro-ultrasound’ OR ‘micro-US’ OR ‘PRI-MUS’ OR ‘ExactVu’) OR (‘multiparametric MRI’ OR ‘mpMRI’ OR ‘multi-parametric magnetic resonance imaging’ OR ‘PI-RADS’) OR (‘PSMA PET’ OR ‘prostate-specific membrane antigen’ OR ‘68Ga-PSMA’ OR ‘18F-DCFPyL’ OR ‘PSMA-11’) OR (‘artificial intelligence’ OR ‘machine learning’ OR ‘deep learning’ OR ‘radiomics’ OR ‘neural network’). Only English-language, peer-reviewed original research articles, systematic reviews, meta-analyses, and major consensus guidelines were included. Case reports, editorials, conference abstracts, and non-peer-reviewed publications were excluded. Two authors (A.R. and O.Z.) independently screened titles and abstracts for relevance. Full texts of potentially eligible articles were retrieved and assessed against predefined inclusion criteria: (1) evaluation of mpMRI, micro-ultrasound, or PSMA PET for prostate cancer detection, localization, or staging; (2) reported diagnostic accuracy metrics (sensitivity, specificity, AUC) or biopsy outcomes; (3) sample size ≥20 patients for original studies. Disagreements were resolved by consensus with a third author (M.B.). Reference lists of included articles were hand-searched for additional relevant studies. A narrative synthesis was conducted due to heterogeneity in study designs, populations, and outcome measures. Results: Multiparametric MRI has become a cornerstone in prostate cancer diagnosis due to its high sensitivity for detecting clinically significant diseases and its role in guiding targeted biopsies. Micro-ultrasound, offering substantially higher spatial resolution than conventional ultrasound, has demonstrated promising diagnostic performance and may represent a cost-effective alternative or complement to in review mpMRI. Meanwhile, PSMA PET imaging has shown high sensitivity for identifying both intraprostatic lesions and metastatic disease. Emerging evidence suggests that combining these imaging modalities may significantly enhance detection rates. Furthermore, artificial intelligence techniques—including machine learning and deep learning algorithms—have shown potential in improving lesion detection, segmentation, and risk stratification in prostate imaging. Conclusion: The integration of multimodal imaging approaches with artificial intelligence represents a promising investigational strategy that may, following prospective validation, improve prostate cancer detection and characterization. Future prospective studies are needed to validate these technologies and define their optimal role in clinical practice.